Related Experiment Video
Updated: Aug 17, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Whipple disease: a case report and review of the literature
Jeannie Muir-Padilla1, Jerome B Myers
1Department of Pathology, Madigan Army Medical Center, Tacoma, Wash 98431, USA.
Abstract:
Whipple disease is a chronic, relapsing, and multisystem disease. It presents a diagnostic challenge for both clinicians and pathologists. Recent advances in isolation and culture have identified the organism responsible for the disease to be a member of the order Actinomycetes designated Tropheryma whipplei. Several immune system changes have been noted in patients with Whipple disease, but whether these are primary or secondary is as yet undetermined. Long-term antibiotic therapy is required, and relapses are common, especially with central nervous system involvement.
Insights
Whipple disease is a chronic multisystem illness that is difficult to diagnose. Tropheryma whipplei bacteria cause this condition, requiring long-term antibiotic treatment and often leading to relapses.
Area of Science:
- Infectious Diseases
- Microbiology
- Immunology
Background:
- Whipple disease is a chronic, relapsing, multisystemic infectious disease.
- It poses significant diagnostic challenges for clinicians and pathologists.
- The causative agent has been identified as Tropheryma whipplei.
Observation:
- Tropheryma whipplei is an Actinomycete bacterium.
- Immune system alterations are observed in patients.
- The primary or secondary nature of these immune changes remains unclear.
Findings:
- The identification of Tropheryma whipplei has advanced understanding of Whipple disease.
- Long-term antibiotic therapy is the standard treatment.
- Relapses are frequent, particularly with central nervous system involvement.
Implications:
- Further research is needed to elucidate the host-pathogen interactions and immune responses.
- Understanding the pathogenesis may lead to improved diagnostic strategies and therapeutic interventions.
- Long-term management and monitoring are crucial for patients with Whipple disease, especially those with neurological complications.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction